GLP-1 receptor agonists for secondary prevention after myocardial infarction and stroke in type 2 diabetes: nationwide real-world evidence

• by Petra Sedova, Michal Vrablík, Petr Kala, Petr Ošťádal, Aleš Tichopád, Aleš Tomek, Robert Mikulik, Gleb Donin, Simona Littnerová, Julia Anna Kent, Jiří Jarkovsky, Virend K Somers, Robert D Brown

• January 7, 2026

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.

• by Kathryn Wighton

• May 14, 2026

• 6 min

Advancing Stroke Care: WashU Medicine Specialists at Barnes-Jewish Hospital Help Chronic Stroke Patients with Innovative Use of Vagus Nerve Stimulation

For years, chronic stroke patients heard familiar feedback regarding their ability to regain strength and mobility after ischemic strokes caused upper-extremity deficits.

• by

• May 6, 2026

• 7 min

Serum uric acid levels and cardiorenal complication prevalence in hypertensive patients before and after the COVID-19 pandemic: a retrospective cross-sectional study from a tertiary traditional Chinese medicine hospital

• by Jin Yuan, Puxue Hua, Xuequan He, Ziyue Huo, Yanan Li, Xiaoying Yang, Rongyan Jia, Fen Li, Yin Lin

• May 21, 2026